Beijing (1)

Hematological Tumors (1)

Recruiting (1)

phase 1 (1)

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. (1)

tqb2825 injection (1)

drug (1)

Industry (1)

Interventional (1)

hematological tumors

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Aug 4, 2022